CASI
Closed
Casi Pharmaceuticals Inc
1.33
+0.15 (+12.71%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.18
Day's Range: 1.18 - 1.33
Send
sign up or login to leave a comment!
When Written:
2.32
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development and commercialization of innovative therapeutics for the treatment of cancer and other diseases. The company is headquartered in Rockville, Maryland, and has operations in China and the United States.
CASI Pharmaceuticals has a portfolio of products that includes both proprietary and licensed drugs. Its lead product candidate, EVOMELA, is a chemotherapy drug used to treat multiple myeloma and other blood cancers. The company also has a pipeline of other oncology drugs, including anti-cancer agents and immunotherapy treatments.
CASI Pharmaceuticals has partnerships and collaborations with several leading pharmaceutical companies and academic institutions. The company's strategic partnerships include collaborations with China's National Cancer Center, the Shanghai Institute of Materia Medica, and the University of Maryland.
CASI Pharmaceuticals was founded in 1991 and went public in 2014. The company is listed on the NASDAQ stock exchange under the ticker symbol "CASI."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
CASI Pharmaceuticals has a portfolio of products that includes both proprietary and licensed drugs. Its lead product candidate, EVOMELA, is a chemotherapy drug used to treat multiple myeloma and other blood cancers. The company also has a pipeline of other oncology drugs, including anti-cancer agents and immunotherapy treatments.
CASI Pharmaceuticals has partnerships and collaborations with several leading pharmaceutical companies and academic institutions. The company's strategic partnerships include collaborations with China's National Cancer Center, the Shanghai Institute of Materia Medica, and the University of Maryland.
CASI Pharmaceuticals was founded in 1991 and went public in 2014. The company is listed on the NASDAQ stock exchange under the ticker symbol "CASI."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!